vosaroxin: Clinical Trials

3 trials of vosaroxin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting, 1 unknown. 3 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 33Completed 1, Recruiting 1, Unknown 1
Phase 22Recruiting 1, Unknown 1

Follow vosaroxin: new trials by email Literature Review of vosaroxin trials Research Report on vosaroxin

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Improve OS in 18 to 60 Year-old Patients, Comparing Daunorubicin Versus High Dose Idarubicin Induction Regimens, High Dose Versus Intermediate Dose Cytarabine Consolidation Regimens, and Standard Versus MMF Prophylaxis of GvHD in Allografted Patients in First CR
Idarubicin, Daunorubicin, HD Cytarabine - Acute Myeloid Leukemia (AML)
Phase 2 / Phase 3RecruitingUniversity Hospital, Angers31002015-01-012026-07-17
Trial to Test the Effects of Adding 1 of 2 New Treatment Agents to Commonly Used Chemotherapy Combinations
Arm A Mylotarg plus DA Versus CPX-351, Arm B Vosaroxin and Decitabine, Arm D Small molecule or Not - Acute Myeloid Leukaemia, Myelodysplastic Syndrome
Phase 2 / Phase 3UnknownCardiff University16002014-10-302020-01-23
Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory AML
vosaroxin + cytarabine, placebo + cytarabine - Acute Myeloid Leukemia
Phase 3CompletedSunesis Pharmaceuticals7112010-12-172018-08-22

Conditions studied

Leukemia, Myeloid, Acute (3)  ·  Hematologic Diseases (1)  ·  Leukemia (1)  ·  Myelodysplastic Syndromes (1)  ·  Neoplasms (1)

Sponsors

Cardiff University (1)  ·  Sunesis Pharmaceuticals (1)  ·  University Hospital, Angers (1)

Countries

France (2)  ·  United Kingdom (2)  ·  Australia (1)  ·  Austria (1)  ·  Belgium (1)  ·  Canada (1)  ·  Czechia (1)  ·  Denmark (1)  ·  Germany (1)  ·  Hungary (1)  ·  Italy (1)  ·  New Zealand (1)  ·  Poland (1)  ·  South Korea (1)  ·  Spain (1)

Top investigators

Linda Neuman, MD (1)  ·  Nigel Russell, Prof (1)

Results publications

PMID 26234174, PMID 40552969, PMID 41237344, PMID 42166362